322 related articles for article (PubMed ID: 30453465)
21. Gastrointestinal absorption enhancement of insulin by administration of enteric microspheres and SNAC to rats.
Qi R; Ping QN
J Microencapsul; 2004 Feb; 21(1):37-45. PubMed ID: 14718184
[TBL] [Abstract][Full Text] [Related]
22. Orally administered heparin for preventing deep venous thrombosis.
Gonze MD; Manord JD; Leone-Bay A; Baughman RA; Garrard CL; Sternbergh WC; Money SR
Am J Surg; 1998 Aug; 176(2):176-8. PubMed ID: 9737627
[TBL] [Abstract][Full Text] [Related]
23. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide.
Xu Y; Amakye WK; Xiao G; Liu X; Ren J; Wang M
Food Chem; 2023 Feb; 401():134059. PubMed ID: 36095999
[TBL] [Abstract][Full Text] [Related]
24. Oral delivery of insulin with the eligen technology: mechanistic studies.
Malkov D; Angelo R; Wang HZ; Flanders E; Tang H; Gomez-Orellana I
Curr Drug Deliv; 2005 Apr; 2(2):191-7. PubMed ID: 16305420
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of oral absorption of panaxnotoginseng saponins].
Han M; Han LM; Wang QS; Bai ZH; Fang XL
Yao Xue Xue Bao; 2006 Jun; 41(6):498-505. PubMed ID: 16927822
[TBL] [Abstract][Full Text] [Related]
26. Hydroxy-safflower yellow A composites: An effective strategy to enhance anti-myocardial ischemia by improving intestinal permeability.
Bao D; Xie X; Cheng M; Zhang K; Yue T; Liu A; Fang W; Wei Y; Zheng H; Piao JG; Xu D; Li Y
Int J Pharm; 2022 Jul; 623():121918. PubMed ID: 35716973
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
29. Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models.
Han M; Fang XL
Acta Pharmacol Sin; 2006 Apr; 27(4):499-505. PubMed ID: 16539852
[TBL] [Abstract][Full Text] [Related]
30. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
31. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats.
Liu H; Yang J; Du F; Gao X; Ma X; Huang Y; Xu F; Niu W; Wang F; Mao Y; Sun Y; Lu T; Liu C; Zhang B; Li C
Drug Metab Dispos; 2009 Dec; 37(12):2290-8. PubMed ID: 19786509
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of salcaprozate sodium and its significance in enhancing pancreatic kininogenase absorption performance.
Lv Z; Luo QD; Tang ZY; Lv XH; Wu T; Huang LK; Tang C
Pharmacol Res Perspect; 2024 Apr; 12(2):e1186. PubMed ID: 38511246
[TBL] [Abstract][Full Text] [Related]
33. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
34. Enhancement by adrenaline of ginsenoside Rg1 transport in Caco-2 cells and oral absorption in rats.
Xiong J; Sun M; Guo J; Huang L; Wang S; Meng B; Ping Q
J Pharm Pharmacol; 2009 Mar; 61(3):347-52. PubMed ID: 19222907
[TBL] [Abstract][Full Text] [Related]
35. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
Kneiszl R; Hossain S; Larsson P
Mol Pharm; 2022 Jan; 19(1):124-137. PubMed ID: 34913341
[TBL] [Abstract][Full Text] [Related]
36. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
37. Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats.
Riley MG; Castelli MC; Paehler EA
Int J Toxicol; 2009; 28(4):278-93. PubMed ID: 19636071
[TBL] [Abstract][Full Text] [Related]
38. Intestinal transport of 3,6'-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models.
Chen Y; Liu X; Pan R; Zhu X; Steinmetz A; Liao Y; Wang N; Peng B; Chang Q
Planta Med; 2013 Oct; 79(15):1434-9. PubMed ID: 24043590
[TBL] [Abstract][Full Text] [Related]
39. Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).
Bittner B; McIntyre C; Tian H; Tang K; Shah N; Phuapradit W; Ahmed H; Chokshi H; Infeld M; Fotaki N; Ma H; Portron A; Jordan P; Schmidt J
Pharmazie; 2012 Mar; 67(3):233-41. PubMed ID: 22530305
[TBL] [Abstract][Full Text] [Related]
40. Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.
Chen G; Fawcett JP; Mikov M; Tucker IG
J Pharm Pharmacol; 2009 Jul; 61(7):953-9. PubMed ID: 19589239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
